Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated p-glycoprotein or MRP overexpression

Journal of Cellular Biochemistry

Volumn 65, Issue 4, 1997, Pages 513-526

  Lee, Jong Seok ^a   Scala, Stefania ^a   Matsumoto, Yoshihito ^a   Dickstein, Bruce ^a   Robey, Rob ^a   Zhan, Zhirong ^a   Altenberg, Guillermo ^b   Bates, Susan E ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c Bldg 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; DNA TOPOISOMERASE; DOXORUBICIN; GLYCOPROTEIN P; MELPHALAN; MITOXANTRONE; PACLITAXEL; VERAPAMIL; VINBLASTINE;

ARTICLE; BREAST CANCER; CELLULAR DISTRIBUTION; DRUG ACCUMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CELL DIVISION; CLONING, MOLECULAR; DAUNORUBICIN; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUORESCENT DYES; HUMANS; ISOENZYMES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PHENOTYPE; POLYMERASE CHAIN REACTION; RHODAMINES; SODIUM CHANNELS; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0000776551     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19970615)65:4<513::AID-JCB7>3.0.CO;2-R     Document Type: Article

References (66)

1. Al-Awqati Q (1995): Regulation of ion channels by ABC transporters that secrete ATP. Science 269:805-806.
2. Allikmets R, Gerrard B, Glavac D, Ravnik-Glavac M, Jenkins NA, Gilbert DJ, Copeland NG, Modi W, Dean M (1995): Characterization and mapping of three new mammalian ATP-binding transporter genes from an EST database. Mamm Genome 6:114-117.
3. Altenberg GA, Young G, Horton JK, Glass D, Belli JA, Reuss L (1993): Changes in intra-or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance. Proc Natl Acad Sci USA 90:9735-9738.
4. Baral E, Auer G (1990): In Vitro effect of doxorubicin on non-proliferating and proliferating epithelial cells. Int J Radiat Oncol Biol Physiol 19:963-965.
5. Barrand MA, Rhodes T, Center MS, Twentyman PR (1993): Chemosensitization and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Eur J Cancer 29A: 408-415.
6. Beck WT, Mueller TJ, Tanzer LR (1979): Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 39:2070-2076.
7. Biedler JL, Peterson RHF (1994): Altered plasma membrane glycoconjugates of Chinese hamster cells with acquired resistance to actinomycin D, daunorubicin, and vincristine. In: Sartorelli AC, Lazo JS, and Bertino JR. (eds): "Molecular Actions and Targets for Cancer Chemotherapeutic Agents." New York: Academic Press, pp 453-482.
8. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger J-D, Rossier BC (1994): Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367:463-467.
9. Center MS (1993): Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug. Cytotech 12:109-125.
10. Chen Y-N, Mickley LA, Schwartz AM, Acton EM, Hwang J, Fojo AT (1990): Characterization of Adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. J Biol Chem 265:10073-10080.
11. Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
12. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG (1993): Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654.
13. Dalton WS, Cress AE, Alberts DS, Trent JM (1988): Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Cancer Res 48:1882-1888.
14. Decker DA, Morris LW, Levine AJ, Pettinga JE, Grudzien JL, Farkas DH (1995): Immunohistochemical analysis of P-glycoprotein expression in breast cancer: Clinical correlations. Ann Clin Lab Sci 25:52-59.
15. Dietel M, Arps H, Lage H, Niendorf A (1990): Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res 50:6100-6106.
16. Doyle LA, Gao Y, Yang W, Ross DD (1995a): Characterization of a 95 kilodalton membrane glycoprotein associated with multidrug resistance. Int J Cancer 62:593-598.
17. Doyle LA, Ross DD, Ordonez JV, Yang W, Gao Y, Tong Y, Belani CP, Gutheil JC (1995b): An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. Br J Cancer 72:535-542.
18. Doyle LA, Ross DD, Sridhara R, Fojo AT, Kaufmann SH, Lee EJ, Schiffer CA (1995c): Expression of a 95 kDa membrane protein is associated with low daunorubicin accumulation in leukaemic blast cells. Br J Cancer 71: 52-58.
19. 1. Cancer Res 56:2904-2907.
20. Duget M, Lavenot C, Harper F, et al. (1983): DNA topoisomerases from rat liver: Physiological variations. Nucleic Acids Res 11:1059-1075.
21. Efferth T, Lohrke H, Volm M (1989): Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res 9:1633-1638.
22. Feller N, Broxterman HJ, Wahrer DCR, Pinedo HM (1995): ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett 368:385-388.
23. Fojo A, Akiyama S, Gottesman MM, Pastan I (1985): Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res 45:3002-3007.
24. Futscher BW, Abbaszadegan MR, Doman F, Dalton WS (1994): Analysis of MRP mRNA in mitoxantrone-selected, multidrug resistant human tumor cells. Biochem Pharmacol 47:1601-1606.
25. Garty H (1994): Molecular properties of epithelial, amiloride-blockade Na+ channels. Faseb J 8:522-528.
26. Gekeler V, Boer R, Ise W, Sanders KH, Schachtele C, Beck J (1995): The specific bisindoylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance. Biochem Biophys Res Comm 206: 119-126.
27. Harker WG, Slade DL, Dalton WS, Meltzer PS, Trent JM (1989): Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. Cancer Res 49:4542-4549.
28. Higgins CF (1995): The ABC of channel regulation. Cell 82:693-696.
29. Hug V, Johnston D, Finders M, Hortobagyi G (1986): Use of growth-stimulatory hormones to improve the in vitro therapeutic index of doxorubicin for human breast tumors. Cancer Res 46:147-152.
30. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D (1996): Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56:988-994.
31. Kang YK, Zhan Z, Regis J, Robey R, Meadows B, Dickstein B, Lee JS, Otsuki T, Stetler-Stevenson MA, Jaffe ES, Solomon D, Wilson WH, Fojo A, Bates SE (1995): Expression of mdr-1 in refractory lymphoma: Quantitation by polymerase chain reaction and validation of the assay. Blood 86:1515-1524.
32. Lai G-M, Chen Y-N, Mickley LA, Fojo AT, Bates SE (1991): P-glycoprotein expression and schedule dependence of Adriamycin cytotoxicity in human colon carcinoma cell lines. Int J Cancer 49:696-703.
33. Lampidis TJ, Bernal SD, Summerhayes IC, Chen LB (1983): Selective toxicity of rhodamine 123 in carcinoma cells in vitro. Cancer Res 43:716-720.
34. Lee JS, Paull K, Alvarez M, Hose C, Monks A, Grever M, Fojo AT, Bates SE (1994): Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute Drug Screen. Mol Pharmacol 46:627-638.
35. Leith CP, Chen IM, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL (1995): Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: Identification of discordant MDR-/efflux+ and MDR+/efflux-cases. Blood 86: 2329-2342.
36. Liang P, Pardee AB (1992): Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-972.
37. Liang P, Averboukh L, Pardee AB (1993): Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 14:3269-3275.
38. Ludescher C, Thaler J, Drach D, Drach J, Spitaler M, Gattringer C, Huber H, Hofmann J (1992): Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Br J Haematol 82:161-168.
39. Maniatis T, Fritsch EF, Sambrook J (1987): Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp 187-207.
40. Marie J, Faussat-Suberville A, Zhou D, Zittoun R (1993): Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr-1 expression. Leukemia 7:825-831.
41. McDonald FJ, Snyder PM, McCray Jr, P.B., Welsh MJ (1994): Cloning, expression, and tissue distribution of a human amiloride-sensitive Na+ channel. Am J Physiol 266:L728-L734.
42. McGrath T, Center MS (1988): Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug. Cancer Res 48: 3959-3963.
43. Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, Rosen N, Fojo AT (1989): Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) differentiating agents. J Biol Chem 264: 18031-18040.
44. Murphy LD, Herzog CE, Rudick JB, Fojo AJ, Bates SE (1990): Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochem 29:10351-10356.
45. Nakagawa M, Schneider E, Dixon KH, Horton J, Kelley K, Morrow C, Cowan KH (1992): Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 human breast cancer cells. Cancer Res 52:6175-6181.
46. Noone PG, Knowles MR (1993): Trends in therapy of abnormal airway epithelial ion and liquid transport. Monaldi Arch Chest Dis 48:140-143.
47. Pelletier H, Millot J-M, Chauffert B, Manfait M, Genne P, Martin F (1990): Mechanisms of resistance to confluent human and rat colon cancer cells to anthracyclines: Alteration of drug passive diffusion. Cancer Res 50:6626-6631.
48. Riordan JR, Ling V (1979): Purification of P-glycoprotein from plasma membrane vesicles of chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem 254:12701-12705.
49. Roepe PD, Wei LY, Cruz J, Carlson D (1993): Lower electrical membrane potential and altered pHi homeostasis in multidrug (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein. Biochem 32:11042-11056.
50. Schneider E, Yamazaki H, Sinha BK, Cowan KH (1995): Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation. Br J Cancer 71:738-743.
51. Schneider J, Romero H (1995): Correlation of P-glycoprotein overexpression and cellular prognostic factors in formalin-fixed, paraffin-embedded tumor samples from breast cancer patients. Anticancer Res 15:1117-1121.
52. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990): New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112.
53. Sognier MA, Zhang Y, Eberle R, Sweet KM, Altenberg GA, Belli J (1994): Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100). Biochem Pharmacol 48:391-401.
54. Summerhayes IC, Lampidis TJ, Bernal SD, Nadakavukaren JJ, Nadakavukaren KK, Sheperd EL, Chen LB (1982): Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc Natl. Acad Sci USA 79:5292-5296.
55. Takano H, Kohno K, Ono M, Uchida Y, Kuwano M (1991): Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer Res 51:3951-3957.
56. Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH, Roe DJ, Trent JM (1991): Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer 63:923-929.
57. Torres RJ, Altenberg GA, Copello JA, Zampighi G, Reuss L (1996): Preservation of structural and functional polarity in isolated epithelial cells. Am J Physiol 270:C1864-1874
58. Twentyman PR, Rhodes T, Rayner S (1994): A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Eur J Cancer 30A:1360-1369.
59. Veneroni S, Zaffaroni N, Daidone MG, Benini E, Villa R, Silvestrini R (1994): Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers. Eur J Cancer 30A:1002-1007.
60. Versantvoort CHM, Broxterman HJ, Pinedo HM, de Vries EGE, Feller N, Kuiper CM, Lankelma J (1992): Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Res 52:17-23.
61. Versantvoort CHM, Broxterman HJ, Lankelma J, Feller N, Pinedo HM (1994): Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 48:1129-1136.
62. Voilley N, Lingueglia E, Champigny G, Mattei M-G, Waldmann R, Lazdunski M, Barbry P (1994): The lung amiloride-sensitive Na+ channel: Biophysical properties, pharmacology, ontogenesis, and molecular cloning. Proc Natl Acad Sci USA 91:247-251.
63. Voilley N, Bassilana F, Migon C, Merscher S, Mattei MG, Carle GF, Lazdunski M, Barbry P (1995): Cloning, chromosomal localization and physical linkage of the beta and gamma subunits of the human amiloride-sensitive sodium channel. Genomics 28:560-565.
64. Waldmann R, Champigny G, Bassilana F, Voilley N, Lazdunski M (1995): Molecular cloning and functional expression of a novel amiloride-sensitive Na+ channel. J Biol Chem 270:27411-27414.
65. Yang C-HJ, Horton JK, Cowan K, Schneider E (1995): Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations. Cancer Res 55:4004-4009.
66. Zaman GJR, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P (1994): The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91:8822-8826.